Kwame Owusu-Edusei

10PUBLICATIONS
24CO-AUTHORS
Pacific Peoples health policyPreventative health careEconomic development policyPolitical economy and social changeEpidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Oct 06, 2026
Cost-effectiveness analysis of pneumococcal conjugate vaccines, PCV21 vs PCV20, in adults aged ≥60 years in Germany.

|Sep 11, 2026
Cost-effectiveness analysis of pneumococcal vaccination of at-risk and high-risk adults aged 18-64 years in Switzerland using PCV21.

|Feb 18, 2026
Delta price cost-effectiveness analysis of PCV21 vs PCV20 use in adults aged ≥65 years in Switzerland.

Muloongo Simuzingili, Andrea Favre-Bulle, Thomas Mutschler

|Apr 24, 2025
Economic evaluation of PCV21 in vaccine-naïve adults aged 19-64 years with underlying medical conditions in the United States.

Zinan Yi, Elamin H Elbasha, Kwame Owusu-Edusei

|Dec 20, 2024
Health and economic impact of the 21-valent pneumococcal conjugate vaccine (V116) for adults in Japan: a delta price approach.

Peter P Mueller, Atsushi Tajima, Kelsie Cassell

|Apr 08, 2024
Structured Literature Review to Identify Human Papillomavirus's Natural History Parameters for Dynamic Population Models of Vaccine Impacts.

Ibrahim Diakite, Bruno Martins, Kwame Owusu-Edusei

Pageof 2

Frequent Collaborators

4 joint publications

Zinan Yi

3 joint publications

Elamin H Elbasha

2 joint publications

Eleana Tsoumani

2 joint publications

Muloongo Simuzingili